Magic mushroom therapy targets stomach pain in early trial
NCT ID NCT06760533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can help people with severe irritable bowel syndrome (IBS). Ten adults with hard-to-treat IBS will receive either a high dose of psilocybin or a placebo (niacin) during a guided session, plus several therapy meetings before and after. The goal is to see if this approach is feasible and reduces abdominal pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBS (IRRITABLE BOWEL SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a postbiotic soothe irritable bowel syndrome?
- Could a new drug calm the gut and stop IBS pain?
- New enzyme blend could be the key to beating bloating
- Could your family history of celiac disease hide a wheat sensitivity?
- Hidden Gut-Brain issues common in kids with IBD, study finds
- Tailored team approach shows promise for IBS sufferers